Antibiotics Market: Increasing Efforts Undertaken by Major Companies for the Development of Advanced Antibiotic Products is Projected to Boost Market Growth at a Healthy CAGR of 4.8% During the Forecast Period of 2019 to 2025

Pune, India, October 2019, MRFR Press Release/- Market Research Future has published a Half-Cooked Research Report on the Global Antibiotics Market.

Market Highlights

According to MRFR analysis, Antibiotics Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 51,835 Million in 2018.

Antibiotics are powerful medicines that fight bacterial infections. They either stop bacteria from reproducing or destroy them. Several types of antibiotics are available, and they are generally available with a prescription in most countries.

The growth of global antibiotics market is driven by various factors such as increasing efforts undertaken by major companies for the development of advanced antibiotic products, development of generic drugs, increasing approval of antibiotic drugs, rise in incidence of chronic and infectious diseases, growing investment opportunities by biotech companies in research and development, is expected to drive the growth of the global antibiotics market.

Several market players currently dominate the global antibiotics market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Segmentation

The global antibiotics market has been segmented based on drug class, spectrum of activity, drug origin, and end user.

The market, based on drug class, has been divided into cephalosporins, penicillin, fluoroquinolones, macrolides, carbapenem, aminoglycosides, sulfonamides, and others. The carbapenem segment is likely to be the fastest growing during the review period due to the increasing incidence of pneumonia, urinary tract infections, which would increase the usage of the carbapenem class of antibiotics. Thus, the rising usage of carbapenem will substantially drive the growth of the antibiotics market.

The global antibiotics market has been bifurcated, based on spectrum of activity, into broad-spectrum antibiotics and narrow-spectrum antibiotics. The broad-spectrum antibiotic segment is expected to hold the majority share of the market as this broad-spectrum antibiotic act against a wide range of diseases, which helps to fight against microbial resistance.

The global antibiotics market has been segmented based on drug origin into natural, semisynthetic, and synthetic. Semisynthetic is expected to be the fastest segment owing to fewer side-effects and has a higher spectrum of activity, which would eventually drive the growth of the antibiotic market in this segment.

The global antibiotics market has been segmented based on drug origin into natural, synthetic, and semisynthetic.

The end user segment of the antibiotics market includes hospitals & clinics, research organizations, and others. The hospitals & clinics segment is expected to hold the largest share of the market as the majority of treatments and procedures are carried out in hospitals, which ultimately increases the usage of antibiotics in the antibiotics market. For instance, according to centers for disease control and prevention (CDC), in 2018, use of the most antibiotics in hospitals increased by nearly 40% for carbapenems and more than 30% for vancomycin. As a result, driving the growth of the antibiotics market.

Key Players

Some of the key players in the Global Antibiotics Market are Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Astellas Pharma Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), Abbott Laboratories (US), GlaxoSmithKline PLC (UK), Sanofi (France), Bayer AG (Germany),  Eli Lilly and Company (US), and Merck & Co., Inc. (US).

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/antibiotics-market-8447

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing adoption of antibiotics. The antibiotics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European antibiotics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The antibiotics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Easy availability of antibiotic drugs and the rise in over-the-counter antibiotic medicines has boosted the growth of the antibiotics market, the market in Asia-Pacific is expected to be the fastest-growing. The antibiotics market in the Middle East & Africa has been divided into the Middle East and Africa.